GENEVA, March 17 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chome, Chuo-kuOsaka-shi, Osaka 541-0045), APPLEMAN, Vicky (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), HUANG, Harry (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), LINEBERRY, Neil (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), RAIZER, Jeffrey (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), ROSENTRATER, Emily (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142) filed a patent application (PCT/IB2025/058946) for "DAZOSTINAG OR CONJUG...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.